Zoster Vaccine or VZIG (for High-Risk Patients) Cost in Korea
Mijan Mijan • July 28, 2025
π Zoster Vaccine or VZIG (for High-Risk Patients) Cost in Korea
In Korea, Zoster vaccines such as Zostavax and Shingrix are commonly used for adults aged 50 and older or immunocompromised patients to prevent shingles (herpes zoster). For high-risk patients with recent exposure, VZIG (Varicella-Zoster Immune Globulin) is administered as a preventive measure. These are offered at vaccination centers, dermatology clinics, and university hospitals.
π Comprehensive Cost Overview
| Vaccine/Immunotherapy Type | Estimated Cost (KRW) | Description |
|---|---|---|
| Zostavax (Live Vaccine, Single Dose) | 130,000 – 160,000 | Live attenuated virus for patients over 50 |
| Shingrix (Recombinant Vaccine, 2 Doses) | 350,000 – 400,000 (Total) | Non-live vaccine with higher efficacy |
| VZIG (Varicella-Zoster Immune Globulin) | 600,000 – 900,000 | Used for post-exposure prophylaxis in high-risk patients |
π§Ύ Detailed Cost Analysis by Component
| Component | Cost (KRW) | Details |
|---|---|---|
| Initial Consultation | 10,000 – 25,000 | Medical assessment and vaccine recommendation |
| Zoster Vaccine (Per Dose) | 130,000 – 200,000 | Based on brand and clinic |
| VZIG Injection (Hospital Setting) | 600,000 – 900,000 | Administered for immunocompromised or newborn exposure |
β Additional & Optional Services Cost
| Optional Service | Additional Cost (KRW) | Purpose |
|---|---|---|
| Antibody Titer Testing | 40,000 – 70,000 | Evaluate existing immunity before vaccine |
| Post-Vaccine Observation (15–30 min) | Included / 5,000 (if billed separately) | Monitor for allergic reaction |
π₯ Clinical Treatment Costs
| Facility Type | Estimated Total Cost (KRW) | Includes |
|---|---|---|
| Local Clinics (Vaccine Only) | 130,000 – 170,000 | Consultation + Single vaccine dose |
| University Hospitals (High-Risk Management) | 650,000 – 1,000,000+ | VZIG + monitoring + diagnostics |
New paragraph
